A functional adaptive immune system, in which tumour antigens are recognised as foreign and eliminated, is fundamental for preventing cancer development and progression.1 Research on cancer immunity and immunotherapy has mainly focused on the antitumor activity of cytotoxic CD8+ T cells (CTL), but cumulative data also highlight a major role of CD4+ T cells. The gene discussed is CD4; the disease is cancer.